000			01955 a2200565 4500
005			20250514231434.0
264		0	_c20050804
008			200508s 0 0 eng d
022			_a0007-0963
024	7		_a10.1111/j.1365-2133.2005.06661.x _2doi
040			_aNLM _beng _cNLM
100	1		_aGottlieb, A B
245	0	0	_aOral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial. _h[electronic resource]
260			_bThe British journal of dermatology _cJun 2005
300			_a1219-27 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAbdominal Pain _xchemically induced
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBlood Glucose _xanalysis
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPsoriasis _xblood
650	0	4	_aSeverity of Illness Index
650	0	4	_aSkin _xpathology
650	0	4	_aSleep Initiation and Maintenance Disorders _xchemically induced
650	0	4	_aStatistics as Topic
650	0	4	_aTacrolimus _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aGriffiths, C E M
700	1		_aHo, V C
700	1		_aLahfa, M
700	1		_aMrowietz, U
700	1		_aMurrell, D F
700	1		_aOrtonne, J-P
700	1		_aTodd, G
700	1		_aCherill, R
700	1		_aMarks, I
700	1		_aEmady-Azar, S
700	1		_aPaul, C F
773	0		_tThe British journal of dermatology _gvol. 152 _gno. 6 _gp. 1219-27
856	4	0	_uhttps://doi.org/10.1111/j.1365-2133.2005.06661.x _zAvailable from publisher's website
999			_c15608563 _d15608563